New York, NY
- Paul Hastings LLP, a leading global law firm, announced today that David Shine
, who is best known for his work on healthcare mega mergers, has joined the firm as a partner and chair of the firm’s Mergers and Acquisitions practice in New York. He joins from Fried Frank, where he was co-head of the Mergers and Acquisitions practice.
“David’s arrival advances our goal of bringing on talented lawyers in key areas as we continue to grow our practices across our global network,” said Barry Brooks
, chair of the New York office of Paul Hastings. “Our lateral partner investments have helped us to become a major player in the Leveraged Finance, Latin America and White Collar and Investigations practices, and David’s addition will allow us to add M&A to that list,” he added.
“We continue to grow our M&A capabilities, with a focus on key industries, such as life sciences and healthcare, and David’s addition marks another important step in our efforts,” said Elizabeth Noe
, chair of the Corporate practice at Paul Hastings. “Adding a well-known M&A lawyer like David, who has advised on some of the largest and most complex healthcare transactions, positions Paul Hastings to capitalize on the resurgence that’s taking place in the M&A market,” she added.
"Fried Frank has been, and will certainly continue to be, a great firm at which to practice M&A and so my decision to leave was very difficult,” said Mr. Shine. “But I am extremely excited about the challenge and the opportunity to help broaden and deepen the M&A practice at Paul Hastings. The Paul Hastings platform, with its global reach, offers me a significant change from the more geographically focused approach at Fried Frank," he added.
Mr. Shine's practice is focused on mergers and acquisitions, private equity investments, and joint venture transactions. He has substantial experience in the healthcare, aerospace and defense, energy, telecom and financial services industries. Representative clients have included Merck & Co., Inc.; Northrop Grumman Corporation; GE Capital; Medco Health Solutions, Inc.; and Vodafone Group Plc.
Mr. Shine was named a "Dealmaker of the Week
" by The American Lawyer
for his role advising Merck in its $41 billion merger with Schering-Plough. Mr. Shine is consistently recognized as a leading individual by Chambers USA
: America's Leading Lawyers for Business and Chambers Global
: The World's Leading Lawyers for Business in Corporate/M&A. He is also consistently recognized by Legal 500
in M&A: Mega-Deals.
Mr. Shine has been quoted in periodicals such as The Wall Street Journal
in connection with public M&A matters and has written articles addressing a broad range of legal topics. His articles have appeared in The M&A Lawyer
and GC New York
, among others.
Mr. Shine is a director of New Classrooms Innovation Partners, a not-for-profit K-12 education reform company, which provides multi-modal learning to public school students in four states.
The arrival of Mr. Shine follows the addition of Samuel Waxman
, who was previously an M&A partner and co-chair of Shearman & Sterling’s Intellectual Property Transactions practice.
Paul Hastings is a leading global law firm with a strong presence throughout Asia, Europe, Latin America, and the United States. Through a collaborative approach, entrepreneurial spirit, and commitment to client service, the professionals of Paul Hastings deliver innovative solutions to many of the world’s top financial institutions and Fortune 500 companies.